Pancreas Tumor

2

Review clinical trials related to Pancreas Tumor. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of Resection Techniques for Pancreatic Tumors

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Participants needed: 431
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Methodist Health SystemUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Patients that have undergone pancreatic or liver resection surgeries from Januar... [+1]

Patients that have not undergone pancreatic resection surgeries [+1]

Status: Not yet recruiting

Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort

Colorectal and pancreatobiliary cancers are the most common digestive cancers. Their incidence has particularly increased over the last few decades, leading to suspicion that environmental factors are involved. In addition, strategies for the therapeutic management of these cancers are evolving in the context of the development of immunotherapies. Tumor microenvironment is a potential source of new diagnostic, prognostic and predictive markers and new therapeutic targets. The links between tumor microenvironment and modulation of the immune system in colorectal and pancreatobiliary cancers are poorly understood. Molecular classifications have been proposed for these cancers, but their link with immunity and response to treatment remains to be explored. Objective : explore links between molecular subtypes, tumor microenvironment, host (immune system, pre-metastatic niche, intestinal microbiota, metabolism), and survival (prognostic value), response (predictive value) and tolerance (toxicities) to treatments in digestive cancers, in particular colorectal and pancreatobiliary cancers. Method: Retrospective and prospective monocentric cohort study

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Jan 13, 2021
Eligibility criteria

Colorectal or pancreatic adenocarcinoma or biliary tract adenocarcinoma [+5]

Patient under guardianship, curatorship or safeguarding of justice [+6]